| Risk of psychiatric adverse events among montelukast users V Sansing-Foster, N Haug, A Mosholder, NM Cocoros, M Bradley, Y Ma, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (1), 385-393. e12, 2021 | 40 | 2021 |
| Patterns of early mental health diagnosis and medication treatment in a Medicaid-insured birth cohort D Pennap, JM Zito, PJ Santosh, SE Tom, E Onukwugha, LS Magder JAMA pediatrics 172 (6), 576-584, 2018 | 27 | 2018 |
| Antidepressant use in Medicaid-insured youth: trends, covariates, and future research needs JM Zito, D Pennap, DJ Safer Frontiers in psychiatry 11, 510965, 2020 | 19 | 2020 |
| The impact of a state Medicaid peer-review authorization program on pediatric use of antipsychotic medications D Pennap, M Burcu, DJ Safer, JM Zito Psychiatric services 69 (3), 293-299, 2018 | 16 | 2018 |
| Hispanic residential isolation, ADHD diagnosis and stimulant treatment among Medicaid-insured youth D Pennap, M Burcu, DJ Safer, JM Zito Ethnicity & Disease 27 (2), 85, 2017 | 10 | 2017 |
| Continuity of care and mental health service use among Medicaid-enrolled youths D Pennap, JM Zito, PJ Santosh, SE Tom, E Onukwugha, LS Magder Medical Care 58 (3), 199-207, 2020 | 8 | 2020 |
| Drospirenone-and levonorgestrel-containing oral contraceptives and the risk of gallbladder disease S Jick, D Pennap Contraception 86 (3), 220-223, 2012 | 7 | 2012 |
| Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study E Eworuke, M Shinde, L Hou, MJ Paterson, PB Jensen, JC Maro, A Rai, ... BMJ open 13 (4), e070985, 2023 | 5 | 2023 |
| The use of analgesics for intentional self-poisoning: trends in US poison center data J Apata, DD Pennap, AD Mosholder Journal of psychiatric research 163, 402-405, 2023 | 4 | 2023 |
| Suicide poisoning mortality: a comparison of the national poison data system and centers for disease control national dataset J Apata, D Pennap, Y Ma, A Mosholder Injury Prevention 30 (1), 81-83, 2024 | 2 | 2024 |
| Risk of hospitalized depression and intentional self-harm with brand and authorized generic sertraline DD Pennap, RS Swain, EC Welch, J Bohn, JG Lyons, S Dutcher, ... Journal of affective disorders 296, 635-641, 2022 | 1 | 2022 |
| Comparing the centers for medicare and medicaid services (CMS) enrollment database death dates to the national death index (NDI) D Pennap, S Swain, S Akhtar, J Liao, Y Wei, J Li, M Wernecke, T MaCurdy, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 401-402, 2020 | 1 | 2020 |
| Comparing the Centers for Medicare and Medicaid Services (CMS) enrollment data death dates to the National Death Index (NDI) D Pennap, RS Swain, S Akhtar, J Liao, Y Wei, J Li, M Wernecke, ... Pharmacoepidemiology and Drug Safety 33 (3), e5772, 2024 | | 2024 |
| Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 coding J Apata, JG Lyons, MC Bradley, Y Ma, ME Kempner, I Kim, E Eworuke, ... Journal of asthma, 1-10, 2023 | | 2023 |
| Assessing the Risk of Intentional Self-Harm in Montelukast Users: An Observational Study in the Sentinel System Using ICD-10 Coding J Apata, JG Lyons, MC Bradley, Y Ma, ME Kempner, I Kim, E Eworuke, ... AACAP's 70th Annual Meeting, 2023 | | 2023 |
| Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare Beneficiaries DJ Graham, HS Izurieta, D Zhang, A Avagyan, H Lyu, R Wiederhorn, Y Lu, ... The American Journal of Medicine 136 (10), 1018-1025. e3, 2023 | | 2023 |
| Suicide poisoning mortality: A comparison of the national poison control center and CDC national datasets S Perez-Vilar, J Apata, D Pennap, A Mosholder PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 154-154, 2022 | | 2022 |
| Trends in the use of non-prescription medications for intentional self-poisoning: A review of data from the United States poison control centers S Perez-Vilar, J Apata, D Pennap, A Mosholder PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 52-52, 2022 | | 2022 |
| Impact of angiotensin-receptor-blocker (ARB) recalls due to nitrosamine contamination on arb utilization in the US, Canada, and Denmark E Eworuke, M Shinde, L Hou, M Paterson, P Jensen, J Maro, A Rai, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 184-184, 2022 | | 2022 |
| Risk of intentional self harm and suicide among 5-alpha reductase inhibitor users and alpha-blocker users S Akhtar, D Pennap, A Ajao, E Boley, S Dharmarajan, K Naik, N Flowers, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 281-282, 2022 | | 2022 |
Thiyagu RajakannanSenior Researcher | Practice Hub LeadVerified email at mail.nih.gov
